Ajooni Biotech Quarterly Results

Pros & Cons

POSITIVES

Revenue growth indicates increased market demand in the latest quarter, building on a consistent upward trend over the past year.
Gross margin improvement suggests better cost management and operational efficiency compared to previous periods.
Strong net profit reflects effective expense control, contrasting with prior quarters where profitability was more volatile.

NEGATIVES

Declining operating margin signals potential challenges in maintaining cost efficiency amidst rising production costs.
Inventory turnover has decreased, indicating possible overstock issues that could impact liquidity.
Cash flow from operations has shown volatility, raising concerns about sustainability in funding growth initiatives.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	19.48	20.05	19.58	25.66	25.72	34.04	29.27	31.27
Expenses	18.84	20.71	17.99	24.70	24.96	33.11	28.26	30.55
Operating Profit	0.64	-0.66	1.59	0.96	0.77	0.93	1.01	0.72
Other Income	0.29	1.57	0.26	0.04	0.31	0.39	1.34	0.65
Interest	0.19	0.12	0.11	0.15	0.06	0.07	0.06	0.08
Depreciation	0.21	0.21	0.24	0.22	0.23	0.24	0.38	0.25
Profit Before Tax	0.52	0.58	1.50	0.63	0.79	1.01	1.91	1.03
Tax	0.12	0.14	0.58	0.16	0.18	0.28	0.37	0.25
Net Profit	0.40	0.44	0.92	0.47	0.61	0.73	1.54	0.78
Eps in Rs	0.23	0.25	0.10	0.03	0.04	0.04	0.09	0.02